THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 118 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 7.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,207 | -61.3% | 139,898 | -53.5% | 0.01% | -58.6% |
| Q2 2023 | $3,116 | -99.4% | 301,080 | +507.1% | 0.03% | +480.0% |
| Q3 2022 | $502,000 | +253.5% | 49,596 | +214.8% | 0.01% | +150.0% |
| Q2 2022 | $142,000 | -57.9% | 15,756 | -55.4% | 0.00% | 0.0% |
| Q1 2022 | $337,000 | -18.6% | 35,289 | -6.0% | 0.00% | 0.0% |
| Q4 2021 | $414,000 | +76.9% | 37,553 | +132.5% | 0.00% | 0.0% |
| Q2 2021 | $234,000 | +17.0% | 16,150 | +64.3% | 0.00% | 0.0% |
| Q1 2021 | $200,000 | -35.7% | 9,830 | -53.4% | 0.00% | -77.8% |
| Q3 2020 | $311,000 | -12.4% | 21,083 | +24.5% | 0.01% | -18.2% |
| Q2 2020 | $355,000 | – | 16,928 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |